UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF NOVEMBER 2019


COMMISSION FILE NUMBER 001-38976 

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F.

Form 20‑F       Form 40‑F 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1)

Yes       No     

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7)

Yes       No     

Exhibit 99.1 to this report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statement on Form S-8 (File No. 333-232693) and in the outstanding prospectus contained in such registration statement.

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

GENMAB A/S

 

 

 

 

BY:

/s/ David A. Eatwell

 

 

Name: David A.Eatwell

 

 

Title: Executive Vice President & Chief Financial Officer

 

DATE: November 6, 2019 

 

EXHIBIT INDEX

A

 

Exhibit

Description of Exhibit

 

 

99.1

Interim Report Dated November 6, 2019     

 

Genmab A S (PK) (USOTC:GNMSF)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Genmab A S (PK) Charts.
Genmab A S (PK) (USOTC:GNMSF)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Genmab A S (PK) Charts.